|By PR Newswire||
|April 22, 2014 07:00 AM EDT||
SWANSEA, Wales, April 22, 2014 /PRNewswire/ --
Creates Cellnovo France
Cellnovo, the leading innovator in Mobile Diabetes Management and insulin patch pump technologies, announces the appointments of three experienced executives to the senior management team. Bart Bergstein has been appointed as Chief Financial Officer, Steve Bubrick as Vice President Global Marketing and Business Development, and Didier Moire as Area Director of newly created Cellnovo France.
Bart Bergstein has a 24 year track record in the financial industry including 14 years in Venture Capital. After joining the private equity arm of ABN AMRO in 1997, Bart established the AMRO Life Sciences Team that later spun out as Forbion Capital Partners.
Steve Bubrick has more than 20 years of experience in the diabetes industry. He joins Cellnovo from Asante Solutions where he held the position of Vice President Commercial Operations. Prior to Asante, Steve held senior commercial positions at Insulet, Abbott, Therasense and Lifescan where he was involved in bringing disruptive monitoring and insulin delivery products to markets worldwide. Steve will also be in charge of laying the foundations of Cellnovo's business in North America, starting with overseeing its regulatory filing process.
Recognising the importance of the diabetes market in France, Cellnovo has created a subsidiary in the country with an office in Paris, where Didier Moire will be based and responsible for sales in France, Belgium and Luxembourg. Didier has more than 25 years' experience in Medical Technology and Diagnostics. He was previously Managing Director France/Benelux for Immucor and also held senior positions in Chiron and Novartis.
Eric A. Beard, Executive Chairman of Cellnovo, said: "I am absolutely delighted to welcome Bart, Steve and Didier to the Cellnovo senior management team. All three are experienced executives and entrepreneurs who will be major contributors to the success of the Company and the launch of our novel insulin delivery and diabetes management technologies."
Cellnovo, a UK-based medical device company, is a leading innovator in Mobile Diabetes Management technology. The Company's proprietary Diabetes Management System comprises a wireless connected patch pump, mobile touchscreen handset/controller with an integrated blood glucose meter and applications. This system provides intuitive operation, wireless Internet connectivity and real-time tracking, all industry firsts which represent a revolution for insulin pump technology. For further information, please visit http://www.cellnovo.com.
May. 4, 2016 09:00 PM EDT Reads: 1,394
May. 4, 2016 07:30 PM EDT Reads: 1,690
May. 4, 2016 07:00 PM EDT Reads: 1,305
May. 4, 2016 07:00 PM EDT Reads: 1,268
May. 4, 2016 05:30 PM EDT Reads: 1,380
May. 4, 2016 05:15 PM EDT Reads: 387
May. 4, 2016 05:00 PM EDT Reads: 1,318
May. 4, 2016 04:30 PM EDT Reads: 824
May. 4, 2016 03:30 PM EDT Reads: 627
May. 4, 2016 03:00 PM EDT Reads: 1,049
May. 4, 2016 03:00 PM EDT Reads: 1,175
May. 4, 2016 02:00 PM EDT Reads: 1,224
May. 4, 2016 02:00 PM EDT Reads: 1,284
As the rapid adoption of containers continues, companies are finding that they lack the operational tools to understand the behavior of applications deployed in these containers, and how to identify issues in their application infrastructure. For example, how are multiple containers within an application impacting each other’s performance? If an application’s service is degraded, which container is to blame? In the case of an application outage, what was the root cause of the outage?
May. 4, 2016 01:45 PM EDT Reads: 1,114